|
|
Aspen - business update and trading statement
During the six months ended 31 December 2025 ("H1 2026") the Group focused on the execution of its communicated strategic priorities outlined to stakeholders in a SENS announcement published on 29 December 2025 and during the stakeholder engagement call held on 15 January 2026. This business update will cover the performance of the Group for H1 2026 followed by anticipated prospects for the full year ending 30 June 2026. The Group delivered an encouraging performance for H1 2026 supported by the continued strong momentum in Commercial Pharmaceuticals and solid progress in the reshaping of its sterile finished dose form ("FDF") Manufacturing facilities in South Africa and France. One- off restructure costs of circa R700 million relating to these sterile FDF Manufacturing facilities have been incurred in H1 2026 and have negatively impacted earnings ("EPS") and headline earnings ("HEPS") per share. H1 2026 should be viewed as transitional with stronger performance anticipated in the second half of FY 2026, as the benefits of operational improvements and reshaping within Manufacturing are progressively realised.
Earnings ranges
Aspen is currently finalising its interim financial results for the six months ended 31 December 2025.
Earnings measures, Expected decrease (%), Expected range 31 December 2025 (CPS) and Reported 31 December 2024 (CPS)
NHEPS - -24% to -19%; 550.4 to 586.6; 724.2
HEPS - -38% to -33%; 400.1 to 432.4; 645.4
EPS - -41% to -36%; 317.2 to 344.1; 537.7
Aspen intends to release its results for the six months ended 31 December 2025 on Tuesday, 3 March 2026 via JSE SENS at 13:00 (SAST, GMT+2), with a presentation to members of the investment community, in-person, at the Absa Healthcare Conference, hosted at The Vineyard Hotel, Cape Town and via webcast on Wednesday, 4 March 2026 at 08:30 (SAST, GMT+2).
|
|
Click here for original article
|
| |
| |
| Click here for full news archive for this company |
|
| Closing price data source: JSE Ltd. All other statistics calculated by ProfileData. |
| |
|
|
